153 related articles for article (PubMed ID: 24641446)
1. One platform comparison of solubilization potential of dendrimer with some solubilizing agents.
Jain S; Kesharwani P; Tekade RK; Jain NK
Drug Dev Ind Pharm; 2015 May; 41(5):722-7. PubMed ID: 24641446
[TBL] [Abstract][Full Text] [Related]
2. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
3. Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes.
Gupta U; Agashe HB; Jain NK
J Pharm Pharm Sci; 2007; 10(3):358-67. PubMed ID: 17727799
[TBL] [Abstract][Full Text] [Related]
4. Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.
Tekade RK; Tekade M; Kumar M; Chauhan AS
Pharm Res; 2015 Mar; 32(3):910-28. PubMed ID: 25205461
[TBL] [Abstract][Full Text] [Related]
5. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes.
Pooja D; Kulhari H; Singh MK; Mukherjee S; Rachamalla SS; Sistla R
Colloids Surf B Biointerfaces; 2014 Sep; 121():461-8. PubMed ID: 25063311
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates.
Patel SK; Gajbhiye V; Jain NK
J Drug Target; 2012 Dec; 20(10):841-9. PubMed ID: 22994427
[TBL] [Abstract][Full Text] [Related]
8. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
[TBL] [Abstract][Full Text] [Related]
9. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
Sharma S; Verma A; Teja BV; Shukla P; Mishra PR
Eur J Pharm Sci; 2015 Mar; 69():51-60. PubMed ID: 25559064
[TBL] [Abstract][Full Text] [Related]
10. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
[TBL] [Abstract][Full Text] [Related]
11. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles.
Cho YW; Lee J; Lee SC; Huh KM; Park K
J Control Release; 2004 Jun; 97(2):249-57. PubMed ID: 15196752
[TBL] [Abstract][Full Text] [Related]
12. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H
Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237
[TBL] [Abstract][Full Text] [Related]
14. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Bhatt H; Ghosh B; Biswas S
Int J Pharm; 2019 Feb; 557():329-341. PubMed ID: 30599231
[TBL] [Abstract][Full Text] [Related]
15. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
Huo MR; Zhang Y; Zhou JP; Lü L; Liu H; Liu FJ
Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of triazine based dendrimers for delivery of antitumor agent.
Bansal KK; Kakde D; Gupta U; Jain NK
J Nanosci Nanotechnol; 2010 Dec; 10(12):8395-404. PubMed ID: 21121345
[TBL] [Abstract][Full Text] [Related]
17. Hydroxypropyl-β-cyclodextrin-graphene oxide conjugates: Carriers for anti-cancer drugs.
Tan J; Meng N; Fan Y; Su Y; Zhang M; Xiao Y; Zhou N
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():681-7. PubMed ID: 26838897
[TBL] [Abstract][Full Text] [Related]
18. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
19. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
20. Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel.
Ooya T; Lee J; Park K
Bioconjug Chem; 2004; 15(6):1221-9. PubMed ID: 15546187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]